Supadopa TR Capsule 61.25 mg + 245 mg is a combination medication containing Levodopa and Carbidopa in an extended-release (TR) formulation, specifically designed for the management of Parkinson’s disease. Parkinson’s disease is a progressive neurological disorder characterized by tremors, stiffness, slow movement, and postural instability. The extended-release formulation ensures a steady release of medication, maintaining stable dopamine levels and minimizing motor fluctuations throughout the day.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Uses and Benefits

• Parkinson’s Disease Management: Reduces tremors, rigidity, bradykinesia (slowness of movement), and postural instability.

• Extended Symptom Control: The TR formulation provides sustained dopamine levels, reducing “off” periods and enhancing motor performance.

• Combination Therapy: Carbidopa prevents the premature conversion of Levodopa to dopamine outside the brain, enhancing efficacy and reducing side effects like nausea.

• Improved Daily Functioning: Supports mobility, independence, and quality of life for patients with Parkinson’s disease.

Mechanism of Action

• Levodopa: Converts into dopamine in the brain, replenishing the depleted neurotransmitter responsible for movement control.

• Carbidopa: Inhibits peripheral conversion of Levodopa, allowing more of the drug to reach the brain and minimizing side effects.

• Extended-Release (TR): Gradually releases the medication over time, ensuring steady dopamine levels and consistent symptom management.

Dosage and Administration

• Administration: Take orally with water. Capsules should be swallowed whole; do not crush, chew, or break.

• Timing: Can be taken with or without food; avoid high-protein meals which may reduce absorption.

• Dosage: Individualized according to severity of symptoms and patient response. Typically administered 1–2 times daily under medical supervision.

• Monitoring: Regular follow-up with a neurologist is recommended to adjust the dose and monitor effectiveness.

Precautions and Safety Information

• Medical History: Inform your doctor if you have heart disease, kidney or liver dysfunction, glaucoma, psychiatric disorders, or a history of ulcers.

• Pregnancy and Lactation: Use only under medical supervision.

• Drug Interactions: Avoid non-selective MAO inhibitors, certain antipsychotics, and other medications that may interfere with dopamine levels.

• Activity Caution: May cause dizziness or drowsiness; avoid driving or operating machinery until the effects are known.

Possible Side Effects

Supadopa TR Capsule is generally well tolerated. Common side effects may include:

• Nausea, vomiting, or loss of appetite

• Dizziness or lightheadedness

• Dyskinesia (involuntary movements)

• Sleep disturbances, vivid dreams, or confusion

• Rarely, hypotension or psychiatric symptoms

Side effects can often be minimized by adjusting the dosage and maintaining a consistent administration schedule.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

• Store below 30°C in a cool, dry place.

• Protect from light and moisture.

• Keep out of reach of children.

Supadopa TR Capsule 61.25 mg + 245 mg provides a high-strength, extended-release treatment for Parkinson’s disease, offering stable symptom control, improved motor function, and enhanced quality of life under proper medical supervision.